2-Aminobenzenethiol

We are 2-Aminobenzenethiol CAS:137-07-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2-Aminobenzenethiol
CAS.NO:137-07-5
Synonyms:2-Aminobenzenethiol
ortho-aminothiophenol
2-amino-benzenethiol
o-Mercaptoaniline
 
Physical and Chemical Properties:
Density 1.2±0.1 g/cm3
Boiling Point 234.9±13.0 °C at 760 mmHg
Melting Point 23 °C
Molecular Formula C6H7NS
Molecular Weight 125.191
Flash Point 79.4±0.0 °C
 
Specification:
Appearance:Light yellow to yellow liquid or solid
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Diltiazem(CAS:42399-41-7).

2-Aminobenzenethiol


Related News: INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment.108-73-6 The drug substance is an active product that has completed the synthetic route, and the intermediate is a product in one place in the synthetic route.92-69-3 Some experts said that in the research and development of chemical medicine, the possibility of large medicines is getting smaller and smaller, and with the popularization of precision treatment, small medicines (high-efficiency medicines) are being introduced more and more.3,4-DICHLOROPHENYL ISOTHIOCYANATE CAS:6590-94-9 The Company’s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA.Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK.

Related Products
Product Name
2,2-Dimethoxy-2-phenylacetophenone View Details
N-Boc-L-alaninol View Details
6-Fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid View Details
5′-Deoxy-5-fluorocytidine manufacturer p-Anisidine manufacturer 9-(4-Bromophenyl)-10-phenylanthracene manufacturer 5-Chloro-3-hydroxypyridine manufacturer Calcium phenylpyruvate manufacturer